have demonstrated that low expression of ER correlates with clinical (tumor size, invasion and progression, DA resistance and worse surgical outcome) and pathological (higher Ki-67 index, mitotic count and p53 expression) factors of worse prognosis (72). Here, MKI67 is linked to neoplasm.